Alessandra Pugi

500 total citations
23 papers, 233 citations indexed

About

Alessandra Pugi is a scholar working on Pediatrics, Perinatology and Child Health, Toxicology and Epidemiology. According to data from OpenAlex, Alessandra Pugi has authored 23 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 5 papers in Toxicology and 5 papers in Epidemiology. Recurrent topics in Alessandra Pugi's work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Epilepsy research and treatment (3 papers). Alessandra Pugi is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Epilepsy research and treatment (3 papers). Alessandra Pugi collaborates with scholars based in Italy, United States and Israel. Alessandra Pugi's co-authors include Alessandro Mugelli, Alfredo Vannacci, Ersilia Lucenteforte, Salvatore De Masi, Renzo Guerrini, Anna Rosati, Francesco Lapi, Valentina Maggini, Giada Crescioli and Eugenia Gallo and has published in prestigious journals such as IEEE Transactions on Vehicular Technology, Epilepsia and BMC Cancer.

In The Last Decade

Alessandra Pugi

22 papers receiving 222 citations

Peers

Alessandra Pugi
Nathanael J. McKeown United States
S Hirsch United States
R. Bakshi Switzerland
S Tirelli Italy
Alessandra Pugi
Citations per year, relative to Alessandra Pugi Alessandra Pugi (= 1×) peers Ali Shamsa

Countries citing papers authored by Alessandra Pugi

Since Specialization
Citations

This map shows the geographic impact of Alessandra Pugi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Pugi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Pugi more than expected).

Fields of papers citing papers by Alessandra Pugi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Pugi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Pugi. The network helps show where Alessandra Pugi may publish in the future.

Co-authorship network of co-authors of Alessandra Pugi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Pugi. A scholar is included among the top collaborators of Alessandra Pugi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Pugi. Alessandra Pugi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bigagli, Elisabetta, et al.. (2023). Unforeseen cytomegalovirus retinopathy following high dose thiotepa and proton irradiation in a pediatric patient with high-risk medulloblastoma: A case report. Frontiers in Pediatrics. 11. 1145941–1145941. 1 indexed citations
2.
Venturini, Elisabetta, Laura Becciolini, Samantha Bosis, et al.. (2022). Sensitivity of three commercial tests for SARS-CoV-2 serology in children: an Italian multicentre prospective study. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 48(1). 192–192. 2 indexed citations
3.
5.
Lucenteforte, Ersilia, Laura Vagnoli, Alessandra Pugi, et al.. (2018). A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study. BMC Cancer. 18(1). 568–568. 12 indexed citations
6.
Pignotti, Maria Serenella, Alessandra Pugi, Salvatore De Masi, et al.. (2016). Consensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease. Pediatric Pulmonology. 51(10). 1088–1096. 19 indexed citations
7.
Maggini, Valentina, Niccolò Lombardi, Stefano Masi, et al.. (2015). A case of pediatric Steven–Johnson Syndrome associated with albuterol consumption. International Immunopharmacology. 27(1). 154–155. 1 indexed citations
8.
Gallo, Eugenia, Valentina Maggini, Margherita Berardi, et al.. (2013). Is green tea a potential trigger for autoimmune hepatitis?. Phytomedicine. 20(13). 1186–1189. 15 indexed citations
9.
Gallo, Eugenia, Ersilia Lucenteforte, Fabio Firenzuoli, et al.. (2013). Herbalists’ perception of risks involving commonly sold medicinal plants in Italy. Complementary Therapies in Medicine. 22(1). 81–86. 5 indexed citations
10.
Pugi, Alessandra, Roberto Bonaiuti, Valentina Maggini, et al.. (2013). Safety profile of antiviral medications: A pharmacovigilance study using the Italian spontaneous-reporting database. American Journal of Health-System Pharmacy. 70(12). 1039–1046. 11 indexed citations
11.
Pugi, Alessandra, et al.. (2013). GRP-004 A New Strategy For Monitoring and Identification of Adverse Drug Reactions in Oncology Patients. European Journal of Hospital Pharmacy. 20(Suppl 1). A2.1–A2. 1 indexed citations
12.
Gori, Luigi, Ersilia Lucenteforte, Francesco Lapi, et al.. (2012). Inappropriate prescription of several herbal remedies in a patient treated with anticancer drugs: a case of subarachnoid haemorrhage. European Journal of Integrative Medicine. 4. 169–169.
13.
Pugi, Alessandra, Silvia Benemei, Maria Teresa Vietri, et al.. (2011). Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review. Journal of Clinical Pharmacy and Therapeutics. 37(2). 245–248. 7 indexed citations
14.
Pugi, Alessandra, Alessandro Bartoloni, Gian María Rossolini, et al.. (2011). Cardiovascular and metabolic safety profiles of the fluoroquinolones. Expert Opinion on Drug Safety. 11(1). 53–69. 10 indexed citations
15.
Lucenteforte, Ersilia, Eugenia Gallo, Alessandra Pugi, et al.. (2011). Complementary and Alternative Drugs Use among Preoperative Patients: A Cross-Sectional Study in Italy. Evidence-based Complementary and Alternative Medicine. 2012. 1–6. 19 indexed citations
16.
Lapi, Francesco, Marco Tuccori, Domenico Motola, et al.. (2010). Safety Profile of the Fluoroquinolones. Drug Safety. 33(9). 789–799. 30 indexed citations
17.
Lapi, Francesco, Maria Teresa Vietri, Emanuele Cecchi, et al.. (2010). Potential drug–drug interactions and radiodiagnostic procedures: an in-hospital survey. Pharmacy World & Science. 32(2). 200–205. 2 indexed citations
18.
Gallo, Eugenia, Elisa Giocaliere, Alessandra Pugi, et al.. (2010). Lack of standardization in a cod liver oil dietary supplement: Three cases of hypervitaminosis D. European Journal of Integrative Medicine. 2(4). 256–256. 1 indexed citations
19.
Re, E. Del, Romano Fantacci, Simone Morosi, & Alessandra Pugi. (2001). Advanced blind adaptive multi-user detector for communications in nonstationary multipath fading channel. IEEE Transactions on Vehicular Technology. 50(6). 1497–1506. 5 indexed citations
20.
Re, E. Del, Romano Fantacci, Simone Morosi, & Alessandra Pugi. (1999). Advanced blind multiuser detection in non stationary multipath fading environment. Dialnet (Universidad de la Rioja). 68–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026